Abstract:Background/Aims: Although small cell lung cancer (SCLC) is sensitive to initial chemotherapy, patients experience tumor recurrence and metastasis, leading to treatment failure. Autophagy as a protective pattern for cell survival in the harsh environment plays an important role in chemoresistance. However, the role of Beclin-1, a key regulator of autophagy in the drug-resistance of SCLC cells is still poorly understood. In the current study, we focused on the effect and regulation of Beclin-1 in chemoresistance of SCLC cells. Methods: We analyzed the levels of Beclin-1 in etoposide/cisplatin (EP) -resistant and -sensitive cell lines, as well as the relationship between Beclin-1 and patients’ chemosensitivity. The function of Beclin-1 in chemoresistant SCLC cells in vitro was measured by MTT, WB, colony formation and flow cytometric analysis. Further rescue experiment was performed after co-transfected with siBeclin-1 and miR-30a mimics or inhibitor. Results: Beclin-1 was upregulated in drug-resistant cells and patients with lower sensitivity to etoposide/cisplatin therapy. Downregulated Beclin-1 attenuated drug sensitivity and colony formation ability of chemoresistant cells. Moreover, inhibition of Beclin-1 resulted in a dramatic decline of autophagy and increase of apoptosis in drug-resistant cells, accompanied by a remarkable reduction in S phase and a raise in G2/M phase of cell cycle. The transfection with miR-30a-5p mimics exhibited an opposite effect. In addition, inhibition of Beclin-1 could partly reverse the effect induced by miR-30a-5p suppression in drug-sensitive cells. Conclusion: Beclin-1 regulated by miR-30a-5p plays a notable role in the drug-resistance of SCLC. Inhibition of Beclin-1 by induction of miR-30a-5p may improve the therapeutic outcome via resensitizing the drug-resistant cells to chemotherapy in SCLC.

Regulation of Autophagy by a Beclin 1-Targeted Microrna, Mir-30A, in Cancer Cells

MiR-23a Modulates X-linked Inhibitor of Apoptosis-Mediated Autophagy in Human Luminal Breast Cancer Cell Lines.

Mir-30D Regulates Multiple Genes in the Autophagy Pathway and Impairs Autophagy Process in Human Cancer Cells

Microrna-30a Sensitizes Tumor Cells to Cis-Platinum Via Suppressing Beclin 1-Mediated Autophagy

MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell.

MIR34Aregulates Autophagy and Apoptosis by Targetinghmgb1in the Retinoblastoma Cell

Decreased Mir-124-3p Expression Prompted Breast Cancer Cell Progression Mainly by Targeting Beclin-1.

MicroRNA-30a Suppresses Autophagy-Mediated Anoikis Resistance and Metastasis in Hepatocellular Carcinoma.

Intensified Beclin-1 Mediated by Low Expression of Mir-30a-5p Promotes Chemoresistance in Human Small Cell Lung Cancer

Regulation of Autophagy by Mir-30D Impacts Sensitivity of Anaplastic Thyroid Carcinoma to Cisplatin.

Degradative autophagy regulates the homeostasis of miRnas to control cancer development

Knockdown of Beclin-1 Impairs Epithelial-Mesenchymal Transition of Colon Cancer Cells.

MicroRNA Targets Autophagy in Pancreatic Cancer Cells During Cancer Therapy

Oncogenic and Tumor Suppressive Roles of Micrornas in Apoptosis and Autophagy

MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib

The Regulating Effect of Autophagy-Related MiRNAs in Kidney, Bladder, and Prostate Cancer

The Emerging Roles of Autophagy-Related MicroRNAs in Cancer

Interaction of autophagy with microRNAs and their potential therapeutic implications in human cancers.

MicroRNA-Mediated Autophagic Signaling Networks and Cancer Chemoresistance

MicroRNA-20a-mediated Loss of Autophagy Contributes to Breast Tumorigenesis by Promoting Genomic Damage and Instability

Biphasic Regulation of Autophagy by Mir-96 in Prostate Cancer Cells under Hypoxia